Through the promotion of the development of inflammatory T cells, including the IFN-γ-producing Th1, and the IL-17-producing Th17 cell subsets, and T cell-dependent tissue inflammation, miR-155 could be a key player in various autoimmune diseases [50], [51]. This evidence concerns the gene IL17A and autoimmune disease.